http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2001018190-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
filingDate 2001-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f663ab0a03db9c9a18858c5a4024a91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51c7d5b9814de49a3bd8106791d741ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1c793d25fe1d8d7d4fc3db2a3126ac3
publicationDate 2001-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2001018190-A1
titleOfInvention Circulating insulin-like growth factor-I and prostate cancer risk
abstract Methods of predicting a propensity to developing prostate cancer are presented. The method consists of measuring the IGF status of individual. Individuals with high IGF status, as compared with normal reference range values, are at increased risk for developing prostate cancer. More particularly, the IGF status may be determined by measuring IGF-I levels and/or IGFBP-3 levels. High IGF and low IGFBP levels are indicative of a high IGF status. A method of determining the prognosis of existing prostate cancers or of monitoring disease progression involves determining the IGF/PSA status of an individual. Individuals with a high IGF/PSA status (both high IGF status and high PSA levels) tend to develop severe prostate cancer and have a poorer overall prognosis.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7192738-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010146059-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007020698-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7348154-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008199886-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7351545-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007020709-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008137049-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005148035-A1
priorityDate 1998-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414984
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12594
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415580
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127701932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128024882
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16161315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226515062
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22958166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6013
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9843174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128760372
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128797476

Total number of triples: 52.